If you have been researching NAD+ supplementation, you have almost certainly hit the NMN vs NR debate. Both are precursors to NAD+ (Nicotinamide Adenine Dinucleotide) — and both have attracted significant peer-reviewed research. For years the industry framed them as rivals. The 2026 clinical data has largely changed that conversation.

This post covers what the science actually says, where the two compounds genuinely differ, and which of our three products — NMN 500mg capsules, NR capsules, or the NMN + NR combination — makes most sense for your specific goals.

What Are NMN and NR — And Why Does NAD+ Matter?

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every cell in your body, central to over 500 enzymatic reactions including cellular energy production (ATP synthesis), mitochondrial function, DNA repair and sirtuin activation. NAD+ levels decline naturally from your 30s onwards — by as much as 50% by age 50 in some tissues. You cannot supplement NAD+ directly as the molecule is too large to cross cell membranes. Instead you take precursors that your body converts into NAD+ through specific metabolic pathways.

The 2026 Head-to-Head Trial — What It Actually Found

This is the most important data point in the NMN vs NR debate to date. At equivalent doses, in the same adults, under identical conditions — both compounds performed equivalently for the primary endpoint of circulating NAD+ elevation. The supplement industry spent years positioning NMN and NR as rivals. The 2026 data shows they are more accurately described as two routes to the same destination.

Both compounds also produced a newly identified benefit — they modulated gut bacteria to increase short-chain fatty acid concentrations, linked to stronger gut barrier function and reduced systemic inflammation. Nicotinamide alone did not produce this effect, suggesting NMN and NR have gut microbiome benefits beyond simple NAD+ conversion.

Full Comparison — NMN vs NR Side by Side

Where NMN Has a Clear Advantage

NMN is one metabolic step closer to NAD+ than NR — it converts directly via NMNAT enzymes without the intermediate NR-to-NMN conversion step. The 2023 identification of the Slc12a8 intestinal transporter confirmed a dedicated direct absorption mechanism for NMN, explaining why responses can vary between individuals based on genetic expression of this transporter.

The most significant clinical differentiator for NMN is metabolic health. A 2022 double-blind trial in Science (Yoshino et al., 25 postmenopausal women) found 250mg/day NMN for 10 weeks significantly improved skeletal muscle insulin sensitivity — a finding not yet replicated with NR. NMN also activates SIRT3, a mitochondrial sirtuin, while NR does not appear to activate SIRT3. With 7 different sirtuins having various cellular effects, the broader sirtuin activation of NMN gives it a wider reach.

Where NR Has a Clear Advantage

NR crosses the blood-brain barrier and raises brain NAD+ levels. A 2026 study (Berven et al., University of Bergen) confirmed that 4 weeks of NR supplementation significantly increased brain NAD+ in healthy adults — NMN was not tested in the brain phase of that study. A 2023 study in Aging Cell found NR can modify biomarkers related to neurodegenerative pathology in humans, suggesting preventive value against Alzheimer's-type neurodegeneration that has not yet been replicated with NMN.

NR also has a longer established human clinical research history. The patented form Niagen® entered human trials earlier and has been tested in broader populations including Parkinson's disease patients, heart failure patients and athletes. A 2018 seminal trial showed 500mg NR twice daily raised blood NAD+ by approximately 60% in healthy middle-aged adults over 6 weeks. If established evidence base is your priority, NR capsules UK offer the longest track record.

The Case for Taking Both — NMN + NR Combined

Given that NMN and NR have unique benefits that the other has not yet replicated — NMN for insulin sensitivity and SIRT3 activation; NR for neurological protection and blood-brain barrier crossing — an increasing number of longevity researchers and biohackers take both compounds together. The logic is straightforward: you capture the full spectrum of published benefits rather than choosing between them.

Our NMN + NR 500mg combination capsules deliver both precursors in a single daily capsule — covering both the direct NMN → NAD+ pathway and the NR neurological research base. This is the option for buyers who do not want to choose and want maximum NAD+ pathway coverage from a single UK-made, in-house encapsulated product.

Who Should Choose What

Why Purity Matters More Than Which Compound You Choose

A 2025 independent analysis found that 87% of tested NR supplements failed to meet their label claims. On the NMN side, approximately 29% of commercial lots showed content variation ranging from -100% to +28.6% versus label claims. A product containing significantly less than stated will not produce the NAD+ elevation shown in clinical trials — regardless of which compound it claims to contain.

Charge Products NMN 500mg capsules are independently tested by Eurofins — the world's largest testing laboratory network — at 99.99% purity via HPLC on every batch. Certificate of Analysis available on request. Batch PC-SE260410. Ranked #1 on Google for "buy NMN capsules Eurofins tested." Encapsulated in-house in our 5 Star Food Hygiene rated UK facility — the same verified powder we sell as NMN powder UK, so you can test the raw material independently before purchasing capsules.

Frequently Asked Questions — NMN vs NR UK